Evaluation of Improvement in Skin and Nail Psoriasis in Bio‐naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO‐VIBRANT Study

OBJECTIVE: To evaluate whether intravenous (IV) golimumab produces improvements in skin and nail symptoms that are concomitant with improvements in quality of life (QoL) and joint symptoms in patients with psoriatic arthritis. METHODS: Patients were randomized to either IV golimumab 2 mg/kg at weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip, Elaine Husni, M., Chakravarty, Soumya D., Kafka, Shelly, Parenti, Dennis, Kim, Lilianne, Hung Lo, Kim, Hsia, Elizabeth C., Kavanaugh, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672302/
https://www.ncbi.nlm.nih.gov/pubmed/33073933
http://dx.doi.org/10.1002/acr2.11180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672302/
https://www.ncbi.nlm.nih.gov/pubmed/33073933
http://dx.doi.org/10.1002/acr2.11180

Ejemplares similares